BioCentury
ARTICLE | Company News

Beaufor Ipsen S.A., West Pharmaceutical deal

March 6, 2000 8:00 AM UTC

WST will develop nasal drug delivery formulations of a Beaufor compound to treat osteoporosis for use in Beaufor's U.K. clinical trials. If the product meets performance criteria, the companies antici...